Brief: Emmaus Life Sciences Provides SEC Reporting Update
Aug 10 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS - 2020 FINANCIAL STATEMENTS RESTATED TO REFLECT
INCREASE
IN NET INCOME ATTRIBUTABLE TO CHANGE IN EQUITY METHOD INVESTMENT
IN JAPANESE AFFILIATE
Source text for Eikon: ID:nPn1wqKXha
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns